Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 3/20 | 0.60 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 2/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
| ▸ | PPARA | Q07869 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4906188 | 0.90 | CYP4F2 (0.74) | CYP4F2CYP4A11MEN1MAPTKMT2A | |
| SCHEMBL11421775 | 0.86 | CYP4F2 (0.55) | CYP4F2CYP4A11MEN1MAPTKMT2A | |
| SCHEMBL28984795 | 0.86 | CYP4F2 (0.61) | CYP4F2CYP4A11MEN1MAPTKMT2A | |
| SCHEMBL717168 | 0.86 | CYP4F2 (0.61) | CYP4F2CYP4A11MEN1MAPTKMT2A | |
| SCHEMBL10871818 | 0.86 | CYP4F2 (0.61) | CYP4F2CYP4A11MEN1MAPTKMT2A | |
| SCHEMBL169939 | 0.86 | CYP4F2 (0.61) | CYP4F2CYP4A11MEN1MAPTKMT2A | |
| SCHEMBL718008 | 0.86 | CYP4F2 (0.61) | CYP4F2CYP4A11MEN1MAPTKMT2A | |
| SCHEMBL87652 | 0.86 | CYP4F2 (0.61) | CYP4F2CYP4A11MEN1MAPTKMT2A | |
| SCHEMBL28462437 | 0.84 | CYP4F2 (0.59) | CYP4F2CYP4A11MEN1MAPTKMT2A | |
| SCHEMBL556885 | 0.84 | CYP4F2 (0.53) | CYP4F2CYP4A11MEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240091195-A1 | MEDICINE COMPRISING GLYCOPYRRONIUM SALICYLATE | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 2024-03-21 | — | — | US | disclosed |
| EP-4289424-A1 | PHARMACEUTICAL COMPRISING GLYCOPYRRONIUM-SALICYLATE | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 2023-12-13 | — | — | EP | disclosed |
| EP-2078524-B1 | ADHESIVE SKIN PATCH | HISAMITSU PHARMACEUTICAL CO (JP) | 2016-08-31 | — | — | EP | disclosed |
| US-20100003313-A1 | ADHESIVE SKIN PATCH | HISAMITSU PHARMACEUTICAL CO.,INC. (JP) | 2010-01-07 | — | — | US | disclosed |
| EP-2078524-A1 | ADHESIVE SKIN PATCH | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 2009-07-15 | — | — | EP | disclosed |
| US-5089267-A | TRANSDERMAL THERAPEUTICAL SYSTEM COMPRISING PHYSOSTIGMINE AS ACTIVE COMPONENT AND PROCESS FOR THE PRODUCTION THEREOF | LTS LOHMANN THERAPIE-SYSTEME GMBH & CO. KG (DE) | 1992-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240091195-A1 | MEDICINE COMPRISING GLYCOPYRRONIUM SALICYLATE | NEU3, NEU4, ST6GAL1 | CYP4F2 938/4885CYP4A11 357/4885MEN1 2581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.